News

Medicine and manufacturing technology provider Novanta (NASDAQ:NOVT) in Q1 CY2025, with sales up 1.1% year on year to $233.4 ...
Clinical research company IQVIA (NYSE: IQV) reported Q1 CY2025 results , with sales up 2.5% year on year to $3.83 billion.